Inogen Inc. (INGN)
NASDAQ
Closed
Oct 23, 2026
Day's Range
6.9852 wk Range
5.04Overview - INGN - Inogen Inc.
Key Statistics
Valuation
Enterprise Value
64.70M
P/E (Trailing)
-7.18
P/E (Forward)
-38.62
PEG Ratio
1.07
Price / Sales (TTM)
0.46
Price / Book
0.94
EV / EBITDA
-8.00
Profitability
Gross Margin
45.50%
Profit Margin
-6.94%
Operating Margin
-5.13%
Return on Assets
-5.84%
Return on Equity
-13.14%
Ownership
Shares Outstanding
26.73M
Float
23.12M
Short % of Shares Outstanding
5.25%
Held by Insiders
12.94%
Held by Institutions
80.43%
Price stats
Beta
1.49
50-Day Avg
5.63
200-Day Avg
6.22
Dividends
Payout Ratio
0.00%
Analyst Consensus
2 analysts
Average price target
$ 12.67Shariah Compliance
Report Date: Feb 16, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - INGN - Inogen Inc.
Peers - INGN - Inogen Inc.
Peer Comparison
Compared with companies in Medical Devices listed on NASDAQ.
Profile Summary - INGN - Inogen Inc.
About
Inogen Inc. is a medical technology company focused on respiratory care for people living with chronic respiratory conditions. The company develops, manufactures, and markets portable oxygen concentrators for homecare use, helping patients receive supplemental long-term oxygen therapy in a more mobile form than…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
